SCHEMBL4722387

SCHEMBL4722387

CCOc1ccccc1-c1[c]c2c(cc1)-c1ccccc1C2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.39
PTPRC P08575 1/20 0.39
HTR2A P28223 1/20 0.37
HTR2C P28335 1/20 0.37
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
GAA P10253 1/20 0.35
HPGD P15428 2/20 0.35
MAPT P10636 2/20 0.35
KDM4E B2RXH2 1/20 0.35
PPARG P37231 1/20 0.35
STAT3 P40763 1/20 0.35
NCOA2 Q15596 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
GABRP O00591 1/20 0.34
GABRD O14764 1/20 0.34
GABRA1 P14867 1/20 0.34
GABRB1 P18505 1/20 0.34
GABRG2 P18507 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4723241 0.89 PDE5A (0.38) ALDH1A1HTR2CMEN1KMT2AHPGD
SCHEMBL4765918 0.88 CYP1A2 (0.41) ALDH1A1MEN1KMT2AMAPTKDM4E
SCHEMBL4723228 0.84 PTGS2 (0.48) ALDH1A1PTPRCMEN1KMT2AGAA
SCHEMBL4921196 0.80 MEN1 (0.38) ALDH1A1PTPRCHTR2CMEN1KMT2A
SCHEMBL217598 0.78 PNMT (0.37) ALDH1A1HTR2CHPGDMAPTKDM4E
SCHEMBL217877 0.76 ALDH1A1 (0.36) ALDH1A1HTR2CMEN1KMT2AHPGD
SCHEMBL217921 0.76 PNMT (0.36) ALDH1A1HPGDMAPTKDM4ENPSR1
SCHEMBL2965677 0.73 ALDH1A1 (0.36) ALDH1A1HPGDMAPTKDM4ECA1
SCHEMBL2974521 0.73 KDM4E (0.36) ALDH1A1PTPRCHPGDMAPTKDM4E
SCHEMBL313500 0.73 PNMT (0.44) ALDH1A1HTR2AHTR2CMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080176857-A1 4-Piperazinnylthieno[2,3-d]Pyrimidine Compounds as Platelet Aggregation Inhibitors PFIZER INC. 2008-07-24 US disclosed
EP-1874780-A1 4-PIPERAZINYLTHIENO[2,3-D]PYRIMIDINE COMPOUNDS AS PLATELET AGGREGATION INHIBITORS Pharmacia & Upjohn Company LLC (US) 2008-01-09 EP disclosed
WO-2006100591-A1 4-PIPERAZINNYLTHIENO [2,3-D] PYRIMIDINE COMPOUNDS AS PLATELET AGGREGATION INHIBITORS PHARMACIA & UPJOHN COMPANY LLC (US) 2006-09-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080176857-A1 4-Piperazinnylthieno[2,3-d]Pyrimidine Compounds as Platelet Aggregation Inhibitors TBXA2R, P2RY4, PF4 ALDH1A1 622/4885PTPRC 1983/4885HTR2A 151/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.